PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.94%
Net income growth under 50% of MRVL's 66.85%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
0.33%
D&A growth well above MRVL's 0.61%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
52.63%
Well above MRVL's 60.00% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-19.48%
Negative yoy SBC while MRVL is 5.13%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
165.88%
Well above MRVL's 86.51% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
125.45%
AR growth well above MRVL's 40.76%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
76.67%
Inventory growth well above MRVL's 29.63%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
18.64%
A yoy AP increase while MRVL is negative at -19.10%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
18200.00%
Growth well above MRVL's 91.99%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
130.00%
Some yoy increase while MRVL is negative at -8.87%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
78.45%
Operating cash flow growth at 50-75% of MRVL's 104.86%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-28.75%
Negative yoy CapEx while MRVL is 0.61%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
28.75%
Some acquisitions while MRVL is negative at -49.20%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-69.64%
Both yoy lines negative, with MRVL at -33.80%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-68.16%
We reduce yoy sales while MRVL is 112.90%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-18.18%
We reduce yoy other investing while MRVL is 2919.61%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-147.76%
We reduce yoy invests while MRVL stands at 551.76%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-45.60%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
9.83%
Buyback growth at 50-75% of MRVL's 18.88%. Martin Whitman questions partial disadvantage in per-share enhancements if competitor repurchases more.